Archives
- Is Investing in SEIS ventures risky? – Join the o2h Chaitime Webinar 10 May, 2023
- Tay Therapeutics, an o2h Ventures portfolio company secures a licensing deal worth over $65 million 05 May, 2023
- o2h Ventures deals pipeline, Knowledge-intensive EIS Fund closing on 5th April 2023 01 March, 2023
- Oct 2022, o2h Ventures Fund Newsletter, KI EIS Closing, EISA events 01 November, 2022
- Aug-Sept 2022, o2h Ventures Fund Newsletter, fifty percent of our companies led by female and more portfolio updates 30 September, 2022
- July 2022, o2h Ventures Fund Newsletter, Deals executed in Alevin Therapeutics, Neurofenix, Five Alarm Bio 01 August, 2022
- May 2022, o2h Ventures Fund Newsletter, SEIS fund close deadline June 30th 2022 28 May, 2022
- o2h Ventures Deal Pipeline, KI EIS Fund closing on 5th April 2022 22 March, 2022
- o2h Ventures makes a follow-on investment into Oxford Drug Design 18 February, 2022
invest in the growth potential of UK life science & AI